Goto Taku, Kishi Takuya, Nakayama Shiki, Onozawa Koji, Yamanouchi Kohei, Kitajima Akira, Fujimoto Kazuma, Takamori Ayako, Sakamoto Yuichiro
Emergency Medicine, Department of Graduate School of Medicine, International University of Health and Welfare, Okawa, JPN.
Emergency, Kouhou-kai Takagi Hospital, Okawa, JPN.
Cureus. 2025 Aug 26;17(8):e91074. doi: 10.7759/cureus.91074. eCollection 2025 Aug.
Patients with renal failure undergoing hemodialysis have a reduced survival rate. Patients with hemodialysis are well known to frequently experience complications such as infections, cerebro-cardiovascular disorders, and gastrointestinal bleeding. At the central hospital where we work in a rural area of Japan, we treat patients with hemodialysis until death, including cases with sudden changes in condition, and all clinical data leading to death are collected. Additionally, compared to previous reports on patients with hemodialysis, our hospital has a higher proportion of elderly patients, and deaths due to cerebro-cardiovascular diseases are also not uncommon. Overseas reports on whether there are differences in the underlying factors between deaths due to cerebro-cardiovascular disease and those due to renal failure in patients with hemodialysis have shown that obesity has a protective effect against deaths due to cerebro-cardiovascular disease, but the protective effect of obesity is limited in deaths due to renal failure. However, there are no reports on this point in Japan. To address this knowledge gap, the primary objective of this study was to compare patient characteristics between groups of patients with hemodialysis at our regional core hospital who died from cerebro-cardiovascular disease and those who died from renal failure. Continuous variables were assessed for normality using the Shapiro-Wilk test and visual inspection of histograms and Q-Q plots. Normally distributed continuous variables were compared using Student's t-test for two groups or one-way analysis of variance for multiple groups. Non-normally distributed continuous variables were analyzed using the Mann-Whitney U test for two groups or the Kruskal-Wallis test for multiple groups. Categorical variables were compared using the Chi-square test or Fisher's exact test. A total of 151 patients diagnosed with end-stage renal disease who were undergoing hemodialysis at the dialysis center of the nephrology department of our hospital as of December 2017 and had no history of cerebro-cardiovascular disease were enrolled in the study. All patients were followed up for five years or until death, whichever occurred first, until December 2022, and continuous monitoring of all diseases was conducted. The annual mortality rate among patients receiving dialysis was relatively high at 7.3%. Compared with the survival group, the mortality group had a higher proportion of males, older age, and bone fractures, as well as lower serum iron levels. Patients who died from cerebro-cardiovascular disease were significantly younger and had higher systolic blood pressure and higher body mass index (BMI) than those who died from renal failure. Additionally, among patients with a BMI of 22 or higher, deaths from cerebro-cardiovascular disease were significantly more common than those from renal failure. In conclusion, among patients with hemodialysis at regional core hospitals in Japan, those who died from cerebro-cardiovascular disease were significantly younger and had higher systolic blood pressure and BMI compared to those who died from renal failure. Although this finding differs from previous reports, it suggests that in the management of patients with hemodialysis at rural core hospitals in Japan, where the elderly population is high, it may be necessary to actively manage blood pressure and atherosclerosis while maintaining a BMI below 22 in younger patients.
接受血液透析的肾衰竭患者生存率较低。众所周知,接受血液透析的患者经常会出现感染、心脑血管疾病和胃肠道出血等并发症。在日本农村地区我们工作的中心医院,我们会对接受血液透析的患者进行直至死亡的治疗,包括病情突然变化的病例,并收集所有导致死亡的临床数据。此外,与之前关于血液透析患者的报告相比,我们医院老年患者的比例更高,因心脑血管疾病导致的死亡也并不罕见。关于血液透析患者中心脑血管疾病死亡和肾衰竭死亡的潜在因素是否存在差异的海外报告显示,肥胖对心脑血管疾病死亡有保护作用,但肥胖对肾衰竭死亡的保护作用有限。然而,日本在这方面尚无相关报告。为填补这一知识空白,本研究的主要目的是比较我们地区核心医院中因心脑血管疾病死亡的血液透析患者组和因肾衰竭死亡的患者组之间的患者特征。使用Shapiro-Wilk检验以及直方图和Q-Q图的目视检查来评估连续变量的正态性。对于正态分布的连续变量,两组之间使用Student's t检验进行比较,多组之间使用单因素方差分析进行比较。对于非正态分布的连续变量,两组之间使用Mann-Whitney U检验进行分析,多组之间使用Kruskal-Wallis检验进行分析。分类变量使用卡方检验或Fisher精确检验进行比较。截至2017年12月,共有151名在我院肾内科透析中心接受血液透析且无心脑血管疾病病史的终末期肾病患者纳入本研究。所有患者均随访5年或直至死亡(以先发生者为准),直至2022年12月,并对所有疾病进行持续监测。接受透析患者的年死亡率相对较高,为7.3%。与存活组相比,死亡组男性比例更高、年龄更大、有骨折情况,且血清铁水平更低。因心脑血管疾病死亡的患者比因肾衰竭死亡的患者明显更年轻,收缩压更高,体重指数(BMI)也更高。此外,在BMI为22或更高的患者中,因心脑血管疾病死亡的情况比因肾衰竭死亡的情况明显更常见。总之,在日本地区核心医院接受血液透析的患者中,因心脑血管疾病死亡的患者比因肾衰竭死亡的患者明显更年轻,收缩压和BMI更高。尽管这一发现与之前的报告不同,但它表明,在日本农村核心医院老年人口较多的情况下,对接受血液透析的患者进行管理时,可能有必要在年轻患者中积极控制血压和动脉粥样硬化,同时将BMI维持在22以下。